T
Tetsuya Babazono
Researcher at University of Toronto
Publications - 133
Citations - 4471
Tetsuya Babazono is an academic researcher from University of Toronto. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 33, co-authored 124 publications receiving 4022 citations.
Papers
More filters
Journal ArticleDOI
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
Hiroyuki Unoki,Atsushi Takahashi,Takahisa Kawaguchi,Kazuo Hara,Momoko Horikoshi,Gitte Andersen,Daniel P.K. Ng,Johan Holmkvist,Knut Borch-Johnsen,Knut Borch-Johnsen,Knut Borch-Johnsen,Torben Jørgensen,Annelli Sandbæk,Torsten Lauritzen,Torben Hansen,Siti Nurbaya,Tatsuhiko Tsunoda,Michiaki Kubo,Tetsuya Babazono,Hiroshi Hirose,Matsuhiko Hayashi,Yasuhiko Iwamoto,Atsunori Kashiwagi,Kohei Kaku,Ryuzo Kawamori,E. Shyong Tai,Oluf Pedersen,Oluf Pedersen,Naoyuki Kamatani,Takashi Kadowaki,Ryuichi Kikkawa,Yusuke Nakamura,Shiro Maeda +32 more
TL;DR: A genome-wide association study using 207,097 SNP markers in Japanese individuals with type 2 diabetes and unrelated controls identified KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) to be a strong candidate for conferring susceptibility to type 1 diabetes.
Journal ArticleDOI
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease
Yoshiharu Tsubakihara,Shinichi Nishi,Takashi Akiba,Hideki Hirakata,Kunitoshi Iseki,Minoru Kubota,Satoru Kuriyama,Yasuhiro Komatsu,Masashi Suzuki,Shigeru Nakai,Motoshi Hattori,Tetsuya Babazono,Makoto Hiramatsu,Hiroyasu Yamamoto,Masami Bessho,Tadao Akizawa +15 more
TL;DR: The Japanese Society for Dialysis Therapy guideline committee, chaired by Dr Y. Tsubakihara, presents the Japanese guidelines, which replace the “2004 JSDT Guidelines for Renal Anemia in Chronic Hemodialysis Patients,” and contain new, additional guidelines for peritoneal dialysis, non‐dialysis (ND), and pediatric chronic kidney disease (CKD) patients.
Journal ArticleDOI
Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.
Atsuyuki Shimazaki,Yoshihiro Kawamura,Akio Kanazawa,Akihiro Sekine,Susumu Saito,Tatsuhiko Tsunoda,Daisuke Koya,Tetsuya Babazono,Yasushi Tanaka,Masafumi Matsuda,Koichi Kawai,Tomohiro Iiizumi,Masahito Imanishi,Toshihiro Shinosaki,Toru Yanagimoto,Minoru Ikeda,Shigeki Omachi,Atsunori Kashiwagi,Kohei Kaku,Yasuhiko Iwamoto,R. Kawamori,Ryuichi Kikkawa,Masatoshi Nakajima,Yusuke Nakamura,Shiro Maeda +24 more
TL;DR: Results indicate that ELMO1 is a novel candidate gene that both confers susceptibility to DN and plays an important role in the development and progression of this disease.
Journal ArticleDOI
Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes.
Hirofumi Makino,Masakazu Haneda,Tetsuya Babazono,Tatsumi Moriya,Sadayoshi Ito,Yasuhiko Iwamoto,Ryuzo Kawamori,Masahiro Takeuchi,Shigehiro Katayama +8 more
TL;DR: In this article, the INNOVATION study (Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy) evaluated the efficacy of an ARB in preventing transition from microalbuminuria to overt nephropathy.
Journal ArticleDOI
Association of the Gene Encoding Wingless-Type Mammary Tumor Virus Integration-Site Family Member 5B (WNT5B) with Type 2 Diabetes
Akio Kanazawa,Syuuichi Tsukada,Akihiro Sekine,Tatsuhiko Tsunoda,Atsushi Takahashi,Atsunori Kashiwagi,Yasushi Tanaka,Tetsuya Babazono,Masafumi Matsuda,Kohei Kaku,Yasuhiko Iwamoto,Ryuzo Kawamori,Ryuichi Kikkawa,Yusuke Nakamura,Shiro Maeda +14 more
TL;DR: The results indicate that the WNT5B gene may contribute to conferring susceptibility to type 2 diabetes and may be involved in the pathogenesis of this disease through the regulation of adipocyte function.